AstraZeneca reports significant proteinuria reduction with Ultomiris in rare kidney disease

AstraZeneca Plc. AZN said its Phase 3 I CAN trial evaluating Ultomiris (ravulizumab) in adults with immunoglobulin A ...
Becker's Hospital Review

AstraZeneca vaccine carries slight risk for bleeding problems, study says

People who receive AstraZeneca’s COVID-19 vaccine have a slightly increased risk of bleeding problems, according to a study published June 9 in Nature Medicine. Researchers observed adults in Scotland ...
Seeking Alpha

AstraZeneca: Solid Results, But Risks Emerge (Rating Downgrade)

The highlight of AstraZeneca's latest results is the maintained full-year outlook despite the recent US drug pricing agreement. AstraZeneca's financials remain robust, with double-digit revenue and ...
WRAL

Europe threatens to restrict vaccine exports after AstraZeneca and Pfizer hit production problems

The European Union is calling out vaccine makers AstraZeneca and Pfizer over delivery delays that could slow its recovery from the pandemic. Officials are even threatening to restrict exports and take ...
The Motley Fool

Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead

AstraZeneca's shares fell off a cliff late last year when it announced the arrest of some of its executives in China, including Leon Wang, the drugmaker's president in the country. That's on top of an ...